Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.3K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.3K
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.3K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.3K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

799
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
799
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

866
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
866
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.1K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.4K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cold-Selective Topological Bias and the Emergence of the First Membranes.

Bio Systems·2026
Same author

Structural basis of complement anaphylatoxin receptor activation by an immunostimulant lead candidate.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Ruliological resilience: Pattern restoration and robustness in Wolfram patterns. A basis for regeneration, not just in Cone Shells?

Bio Systems·2026
Same author

Molecular mechanisms of naturally encoded signaling bias at the complement anaphylatoxin receptors.

Molecular cell·2026
Same author

Pattern regeneration in two-dimensional cellular automata models of bivalve shell symmetry.

Bio Systems·2026
Same author

Description of an independently developed quality assessment tool to meet emergency department credentialing and Emergency Ultrasound Fellowship Accreditation Council guidelines.

The ultrasound journal·2026

Related Experiment Video

Updated: Feb 1, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K

Inflammasomes in CNS Diseases.

Eduardo A Albornoz1, Trent M Woodruff1, Richard Gordon2,3

  • 1School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

Experientia Supplementum (2012)
|December 12, 2018
PubMed
Summary
This summary is machine-generated.

Neuroinflammation, driven by inflammasomes, is central to neurological diseases. Understanding inflammasome activation in brain cells is key to developing new therapies for these conditions.

Keywords:
ASCIL-1βInflammasomeMicrogliaNLRP3NeurodegenerationNeuroinflammation

More Related Videos

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.6K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K

Related Experiment Videos

Last Updated: Feb 1, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

21.4K
Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases
07:47

Longitudinal In Vivo Imaging of the Cerebrovasculature: Relevance to CNS Diseases

Published on: December 6, 2016

7.6K
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
06:52

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages

Published on: May 21, 2018

11.3K

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Neuroinflammation is a hallmark of neurological diseases, stemming from chronic activation of the central nervous system's (CNS) innate immune response.
  • Inflammasomes, intracellular protein complexes, are key mediators, activated by pathogens and damage-associated molecular patterns (DAMPs).

Purpose of the Study:

  • To elucidate the activation mechanisms of brain inflammasomes.
  • To summarize the role of inflammasomes in the pathogenesis and progression of neurological diseases.

Main Methods:

  • Review of scientific literature on inflammasome activation pathways in the CNS.
  • Analysis of the involvement of microglia, macrophages, astrocytes, and neurons in inflammasome-mediated neuroinflammation.

Main Results:

  • Chronic inflammasome activation leads to a cycle of cellular death, tissue damage, and self-propagation of inflammation.
  • Microglia and infiltrating macrophages are primary activators, but astrocytes and neurons also play significant roles.

Conclusions:

  • Understanding inflammasome engagement in neurological diseases is critical for therapeutic development.
  • Targeting chronic inflammasome activation offers a potential strategy for treating CNS pathologies.